KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestMortgage LoansNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesReal Estate - NetRetained EarningsShareholder's EquityTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Cash & Equivalents (2016 - 2026)

Sabra Health Care REIT has reported Cash & Equivalents over the past 17 years, most recently at $116.5 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 414.41% year-over-year to $116.5 million; the TTM value through Mar 2026 reached $116.5 million, up 414.41%, while the annual FY2025 figure was $71.5 million, 18.31% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $116.5 million at Sabra Health Care REIT, up from $71.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $200.6 million in Q3 2025 and troughed at $22.7 million in Q1 2025.
  • A 5-year average of $60.5 million and a median of $49.3 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 95.19% in 2022 and later soared 414.41% in 2026.
  • Year by year, Cash & Equivalents stood at $49.3 million in 2022, then fell by 16.27% to $41.3 million in 2023, then skyrocketed by 46.46% to $60.5 million in 2024, then grew by 18.31% to $71.5 million in 2025, then surged by 62.89% to $116.5 million in 2026.
  • Business Quant data shows Cash & Equivalents for SBRA at $116.5 million in Q1 2026, $71.5 million in Q4 2025, and $200.6 million in Q3 2025.